The EPO published patent application EP3934643A1 for a composition comprising pilocarpine for treating presbyopia, delivered to the eye as a micro-dose stream of droplets. The application was filed by Hyperion DeFi, Inc. with inventors Tsontcho Ianchulev and Luke Clauson. Designated states cover all major European patent convention countries including DE, FR, GB, IT, ES, NL, and others.

This publication is informational and does not impose compliance obligations. Parties interested in the technology, potential freedom-to-operate analysis, or licensing should review the published application at the EPO register. The patent has no associated deadlines or penalties.